A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas

Conditions:   Head and Neck Carcinoma;   Adenocarcinoma;   Recurrent Disease;   Distantly Metastatic Malignant Neoplasm Intervention:   Drug: Anlotinib Sponsor:   Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials